Product
Supportive care
1 clinical trial
1 indication
Indication
Minimal Change DiseaseClinical trial
Efficacy and Safety of Tacrolimus in Combination With Anti-CD20 Monoclonal Antibody (Ripertamab) in the Initial Treatment of Patients With Minimal Change Disease: a Multi-center Randomized Controlled Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2026-04-01